Similar articles

• Immunotherapy in Friend virus leukemia. II. Prevention of friend leukemia by passive administration of immune serum and cells to young mice.

  Wahren B. Wahren B. J Natl Cancer Inst. 1968 Oct;41(4):931-8. J Natl Cancer Inst. 1968. PMID: 5693664 No abstract available.
• Immunization with a single T helper cell epitope abrogates Friend virus-induced early erythroid proliferation and prevents late leukemia development.

  Miyazawa M, Fujisawa R, Ishihara C, Takei YA, Shimizu T, Uenishi H, Yamagishi H, Kuribayashi K. Miyazawa M, et al. J Immunol. 1995 Jul 15;155(2):748-58. J Immunol. 1995. PMID: 7541823
• Immunotherapy of murine leukemia. V. Protection against Friend leukemia virus-induced immune complex glomerulonephritis by passive serum therapy.

  Sanfilippo F, Genovesi EV, Collins JJ. Sanfilippo F, et al. J Natl Cancer Inst. 1981 Sep;67(3):703-17. J Natl Cancer Inst. 1981. PMID: 6456369
• The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model.

  Hasenkrug KJ, Dittmer U. Hasenkrug KJ, et al. Virology. 2000 Jul 5;272(2):244-9. doi: 10.1006/viro.2000.0387. Virology. 2000. PMID: 10873767 Review. No abstract available.
• Genetic resistance to Friend virus.

  Axelrad A. Axelrad A. Ann N Y Acad Sci. 1989;567:26-38. doi: 10.1111/j.1749-6632.1989.tb16456.x. Ann N Y Acad Sci. 1989. PMID: 2679323 Review. No abstract available.